New Delhi: The Central Drugs Standard Control Organisation has alerted states that Indian drug makers are flouting rules as they neither routinely test the ingredients of medicines as per set standards before using them to manufacture formulations nor check the finished products.

Rajeev Singh Raghuvanshi, Drugs Controller General (India) wrote to the states and union territories informing them that though Drug Rules made it mandatory for firms to test “each batch or lot” of raw material used in manufacturing a formulation and “each batch of final product”, the practice was not followed all the time.

The DCGI didn’t disclose the names of the guilty companies or when the inspections were carried out. But his letter written on Oct 7 and released on Wednesday gives reference to the reports o

See Full Page